|
Characteristic
|
Univariate analysis
|
Multivariate analysis
|
|---|
|
HR (95% CI)
|
P value
|
HR (95% CI)
|
P value
|
|---|
|
Chemotherapy-free survival
|
|
DNAH status
|
0.456 (0.248–0.848)
|
0.011
|
0.446 (0.233–0.856)
|
0.015
|
|
TNM stage
|
1.767 (1.010–3.092)
|
0.046
|
1.275 (0.716–2.268)
|
0.409
|
|
R0 resection
|
5.780 (2.464–13.558)
|
< 0.001
|
5.289 (2.097–13.341)
|
< 0.001
|
|
Grade
|
1.327 (0.722–2.439)
|
0.361
| | |
|
Age at diagnosis, y
|
1.010 (0.982–1.308)
|
0.482
| | |
|
Fluoropyrimidine-free survival
|
|
DNAH status
|
0.518 (0.264–0.014)
|
0.055
| | |
|
TNM stage
|
1.485 (1.189–5.192)
|
0.016
|
2.080 (0.961–4.502)
|
0.063
|
|
R0 resection
|
6.295 (2.338–16.963)
|
< 0.001
|
5.136 (1.848–14.275)
|
0.002
|
|
Grade
|
1.429 (0.794–2.575)
|
0.234
| | |
|
Age at diagnosis, y
|
1.019 (0.986–1.053)
|
0.269
| | |
|
Platinum-free survival
|
|
DNAH status
|
0.217 (0.061–0.768)
|
0.018
|
0.137 (0.030–0.629)
|
0.011
|
|
TNM stage
|
1.716 (0.761–3.872)
|
0.193
| | |
|
R0 resection
|
4.184 (1.172–14.932)
|
0.027
|
5.116 (1.415–18.501)
|
0.013
|
|
Grade
|
1.415 (0.454–4.411)
|
0.550
| | |
|
Age at diagnosis, y
|
1.000 (0.959–1.044)
|
0.988
| | |
- Statistically significant values are in italics
